Global Advisory Committee  on Vaccine Safety,  12-13 December 2007.
D001172:Arthritis, Rheumatoid / Q000209:etiology; D002675:Child, Preschool; D020275:Guillain-Barre Syndrome / Q000209:etiology; D017325:Hepatitis B Vaccines / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D007223:Infant; D022321:Japanese Encephalitis Vaccines / Q000009:adverse effects; D008585:Meningitis, Meningococcal / Q000517:prevention & control; D009080:Mucocutaneous Lymph Node Syndrome / Q000209:etiology; D038541:Neisseria meningitidis, Serogroup B / Q000276:immunology; D022243:Rotavirus Vaccines / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects* / Q000627:therapeutic use; D014944:World Health Organization; D022341:Yellow Fever Vaccine / Q000009:adverse effects
D017325:Hepatitis B Vaccines; D022321:Japanese Encephalitis Vaccines; D022243:Rotavirus Vaccines; D014612:Vaccines; D022341:Yellow Fever Vaccine